Search

Abbott Laboratories

Uždarymo kaina

SektoriusSveikatos priežiūra

106.28 1.76

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

104.19

Max

106.71

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-149M

928M

Pardavimai

420M

13B

P/E

Sektoriaus vid.

38.989

50.373

Pelnas, tenkantis vienai akcijai

1.42

Dividendų pajamingumas

2.43

Pelno marža

7.369

Darbuotojai

122,000

EBITDA

-1.3B

1.5B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+14.82% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

2.43%

2.12%

Kitas uždarbis

2027-01-21

Kitas dividendų mokėjimo data

2026-11-16

Kita Ex Dividend data

2027-01-14

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.4B

181B

Ankstesnė atidarymo kaina

104.52

Ankstesnė uždarymo kaina

106.28

Abbott Laboratories Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-10-30 23:06; UTC

Abbott Laboratories shares are trading lower in after-market hours, despite a slight recovery, remaining below Friday's close.

2026-10-29 23:02; UTC

Abbott Laboratories shares advanced in after-market trading, supported by strength in the Health Care Equipment sub-sector, significantly above its 20-day moving average.

2026-10-28 23:02; UTC

Abbott Laboratories is advancing in after-market trading, reflecting notable strength since Wednesday's close, peaking at 1.43% before slightly retracing.

2026-10-27 23:01; UTC

Abbott Laboratories shares advanced in after-market trading, reaching their highest level since Tuesday's close amid strong new home sales data.

2026-10-26 23:11; UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, reflecting a broader market decline that has persisted since Monday's close.

2026-10-23 23:01; UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, experiencing notable volatility after shifting from slight gains to losses.

2026-10-22 23:51; UTC

Abbott Laboratories is gaining modestly in after-market trading, positioned significantly above its 20-day moving average and nearing the upper end of its one-month trading range.

2026-10-21 23:06; UTC

Abbott Laboratories shares are trading slightly higher in after-market hours, amid broader equity gains following a significant decline in U.S. crude oil inventories.

2026-10-20 23:01; UTC

Abbott Laboratories shares are trading lower in after-market hours, continuing a downward trend amid broader weakness in the Health Care Equipment sub-sector.

2026-10-19 23:41; UTC

Abbott Laboratories shares are trading modestly lower in after-market hours after retracing from an early peak above Monday's close.

2026-10-17 00:01; UTC

Abbott Laboratories is trading modestly lower in after-market hours, retracing from a brief uptick earlier.

2026-10-16 23:01; UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, following a brief rise earlier, amid ongoing volatility.

2026-10-15 23:06; UTC

Abbott Laboratories is trading lower in after-market hours, with cumulative returns dipping below Thursday's close after fluctuating during the session.

2026-10-14 23:31; UTC

Abbott Laboratories shares advanced in after-market trading, reflecting strength as they trade above their 20-day moving average and near the upper end of their one-month range.

2026-10-13 20:08; UTC

Abbott Laboratories shares advanced, closing modestly above Monday's close, despite pulling back from an early session high during Tuesday's trading.

2026-10-12 23:06; UTC

Abbott Laboratories is trading higher in after-market hours, continuing a trend of three consecutive daily closes with slight upward movement since Monday's close.

2026-10-10 00:01; UTC

Abbott Laboratories is trading higher in after-market hours, marking the highest cumulative return since Friday's close and showing unusual strength within its one-month range.

2026-10-09 22:01; UTC

Abbott Laboratories shares advanced in after-market trading, reflecting a modest increase since Friday's close while fluctuating around the middle of its one-month range.

2026-10-08 22:45; UTC

Abbott Laboratories shares are trading lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

2026-10-07 23:50; UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

2026-10-06 20:07; UTC

Abbott Laboratories shares fell sharply after an earlier rise, reaching their lowest point of the day and remaining below the 20-day moving average.

2026-10-05 23:05; UTC

Abbott Laboratories is trading slightly higher in after-market hours, while the S&P Global Composite PMI rose to 58.4, indicating strong growth in the U.S. economy.

2026-10-02 20:07; UTC

Social Media
News

Abbott Laboratories upgraded to Buy from Hold by Rothschild & Co Redburn, with a price target increase to $127, as shares trade modestly higher.

2026-10-01 20:07; UTC

Abbott Laboratories shares fell sharply, closing at their lowest point for the session and trading well below the 20-day moving average.

2026-09-30 20:07; UTC

News

Abbott Laboratories launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer, but shares fell amid broader market trends.

2026-09-29 23:00; UTC

Abbott Laboratories is declining in after-market trading, finishing lower for three consecutive sessions and positioned significantly below its 20-day moving average.

2026-09-25 20:07; UTC

Abbott Laboratories' shares are higher amid a broader market rally, recovering from an earlier pullback but still below its 20-day moving average.

2026-09-24 19:51; UTC

Macro Event

Abbott Laboratories shares fell, diverging from recent gains, amid a report showing a slight improvement in U.S. Jobless Claims' 4-week Average.

2026-09-23 20:01; UTC

News

Abbott Laboratories announced a partnership with Berry Street for personalized nutrition support, but shares fell amid broader market reactions to insider trading activity.

2026-09-22 23:41; UTC

Abbott Laboratories is seeing a modest increase in after-market trading, following three consecutive higher daily closes despite being below its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Abbott Laboratories Prognozė

Kainos tikslas

By TipRanks

14.82% į viršų

12 mėnesių prognozė

Vidutinis 121.938 USD  14.82%

Aukščiausias 135 USD

Žemiausias 115 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Abbott Laboratories kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

19 ratings

17

Pirkti

2

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat